Showing 421 - 440 results of 4,279 for search '"pharmacology"', query time: 0.08s Refine Results
  1. 421
  2. 422

    A systematic review of Randomized Controlled Trials about some non-pharmacological interventions for treatment of hypertension: Physical exercise, sodium restriction, weight and alcohol use reduction by Amobi Akonobi, Jawad Khan

    Published 2019-03-01
    “…Discussion and Conclusions: Our findings confirm that physical exercise, sodium restriction, weight and alcohol use reduction are four non-pharmacological interventions effective in the control of hypertension. …”
    Get full text
    Article
  3. 423
  4. 424

    Pharmacological modulation of Sigma-1 receptor ameliorates pathological neuroinflammation in rats with diabetic neuropathic pain via the AKT/GSK-3β/NF-κB pathway by Yuyu An, Shanshan Cao, Leilei Shi, Yuhan Zhang, Xin Wang, Shiyu Yuan, Yongheng Shi, Bin Wang, Jiping Liu, Chao-jun Han

    Published 2025-02-01
    “…The mRNA levels of TNF-α, IL-1β, and cyclooxygenase 2 (COX-2) were reduced. Pharmacological inhibition of Sig-1R with BD1047 (10 μM) abolished Sig-1R-mediated activation of lipopolysaccharide-treated BV-2 microglial cells. …”
    Get full text
    Article
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432

    HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction by Robin Chung, James C Moon, Alexander R Lyon, Charlotte H Manisty, Muhummad Sohaib Nazir, Malcolm Walker, Peter Kellman, Benjamin Dowsing, Daniel Chen, Jessica Artico, Mark Westwood, Hakim-Moulay Dehbi, Rebecca Roylance, Tom Crake, Peter Schmid, Arjun Ghosh, Maria Sol Andres, Joanna Pedra, Orla Worn

    Published 2025-02-01
    “…The Randomised Controlled Trial for the Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction (HER-SAFE) aims to evaluate whether HFT can be safely withdrawn in non-high cardiovascular (CV) risk patients with ‘recovered’ HER2 CTRCD.Methods and analysis This is a multicentre, open-label randomised controlled trial investigating whether withdrawal of HFT is non-inferior to continuation in non-high CV risk, breast cancer survivors with recovered HER2 CTRCD after cancer treatment completion. …”
    Get full text
    Article
  13. 433
  14. 434
  15. 435
  16. 436

    Non-pharmacological Methods Used in the Management of Type 2 Diabetes Mellitus by a Selected Group of People with T2DM in Colombo District, Sri Lanka: A Mixed-Method Study by Lakshani Herath, Manisha Kamalsiri, Perananthan Inthuja, Gayani P Gamage, Dinithi Vidanage

    Published 2024-04-01
    “…The prevalence of T2DM in Sri Lanka is high due to the unhealthy lifestyles of individuals. Both pharmacological and non-pharmacological interventions are practiced by people with T2DM to achieve better glycemic control. …”
    Get full text
    Article
  17. 437
  18. 438
  19. 439
  20. 440

    The Efficacy of Fan Therapy to Alleviate Breathlessness among Lung Cancer Patients by Komang Noviantari

    Published 2024-04-01
    Subjects: “…dyspnea; non-pharmacological therapy; nursing intervention; oncology; respiratory disease.…”
    Get full text
    Article